FDA Warns Drug Makers: Update Drug Listings Or Come Off Market

By Beth Wang / August 13, 2019 at 6:15 PM
FDA warned domestic and foreign drug makers that beginning Sept. 12 it will inactivate drug listings in the National Drug Code (NDC) directory that haven’t been recently updated or certified or that include an establishment with an expired registration. In a Federal Register notice Tuesday (Aug. 13), the agency says that tens of thousands of records in the NDC directory, the NDC Structured Product Labeling Data Elements (NSDE) file and other public drug listing databases could be affected, and it...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.